Items with tag "crispr"

News

CRISPR eliminates heart disease in embryos

American and South Korean scientists have successfully removed a part of the genome of human embryos using CRISPR-Cas9 to eradicate a hereditary heart disease, according to a study published in Na…

Read more

CRISPR companies sharing IPO, will they get along?

Some of the biggest CRISPR-using companies have created an IP-sharing alliance on their technology. CRISPR Therapeutics, Intellia, Caribou Biosciences and ERS Genomics have banded together in an e…

Read more

First human treated with CRISPR

Back in October, CRISPR was applied for the first time in the treatment of a human being. The patient was being treated for an aggressive form of lung cancer. In a form of immunotherapy, patient i…

Read more

CRISPR company Intellia prices IPO

Gene editing company Intellia Therapeutics Inc. (NASDAQ:NTLA) raised $108 million on Thursday through the sale of 6 million shares at $18 in an IPO underwritten by Credit Suisse, Jefferies, Leerin…

Read more

Insights

Why everyone needs to be a part of the CRISPR conversation

Why everyone needs to be a part of the CRISPR conversation

Hetty Helsmoortel is a science communicator who has dedicated herself to bringing research breakthroughs to a broader audience. In her recent book “De Geknipte Genen”, she tackles CRISPR: a revolu…

Read more

Inari: shaking things up in the agriculture business

Inari: shaking things up in the agriculture business

Inari Agriculture has been awarded the 2020 Newcomer of the Year Trophy by Flanders Investment & Trade (FIT). Inari (US) opened its first foreign R&D branch in Ghent’s biotech valley just over a y…

Read more

A new type of power plants to combat climate change

A new type of power plants to combat climate change

The prestigious organization EMBO recently announced several new members, including the appointment of VIB-UGent scientist Prof Wout Boerjan. Boerjan joins over 1800 other EMBO members in what is …

Read more

What’s next for CRISPR crops in the EU?

What’s next for CRISPR crops in the EU?

Genetically Modification Organisms (GMOs) is one of the most hotly debated topics in the news today. Resistance to GMOs has in the past been huge and strict regulations have followed. In July this…

Read more

How CRISPR/Cas9 is improving drug development using zebrafish

How CRISPR/Cas9 is improving drug development using zebrafish

CRISPR/Cas9 came to the attention of scientists everywhere over five years ago. Ever since it hit the main stage, the gene editing technique has stayed in the spotlight, and for good reason. CRISP…

Read more

DuPont Pioneer’s next generation of waxy corn shows the green side of CRISPR-Cas9

DuPont Pioneer’s next generation of waxy corn shows the green side of CRISPR-Cas9

CRISPR-Cas9 is making its way into the agricultural sector. Agricultural heavyweight DuPont Pioneer is clearly taking the lead in bringing the technology into plant breeding: about a year ago, the…

Read more

Dawn of a new era: How CRISPR-Cas9 gene editing cuts beyond science

Dawn of a new era: How CRISPR-Cas9 gene editing cuts beyond science

Every year, the leading scientific journal Science selects its “breakthrough of the year.” The gene-editing tool CRISPR-Cas9 was the runner up in 2013 and 2014, but it finally broke through and ea…

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Janssen Itera Life Science V-Bio Ventures GSK XpandInnovation UGent Flanders.bio Turnstone KU Leuven Biowin

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.